SCHEMBL28453533

SCHEMBL28453533

O=C(O)C1CCN([C@@H]2CCOC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
KDM2B Q8NHM5 1/20 0.36
HRH3 Q9Y5N1 8/20 0.36
LMNA P02545 2/20 0.36
HTR2A P28223 2/20 0.35
HRH1 P35367 2/20 0.35
HTR2B P41595 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTR2C P28335 1/20 0.35
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28442543 1.00 TSHR (0.46) TSHRKDM2BHRH3LMNAHTR2A
SCHEMBL1978050 0.89 TSHR (0.53) TSHRHRH3LMNAKDM4E
SCHEMBL21341447 0.86 TSHR (0.46) TSHRLMNAHTR2AHRH1HTR2B
SCHEMBL1437563 0.84 CHRM1 (0.45) KDM2BHRH3LMNAKDM4E
SCHEMBL21061915 0.80 GSK3B (0.35) KDM2BHRH3LMNA
SCHEMBL21061547 0.80 GSK3B (0.35) KDM2BHRH3LMNA
SCHEMBL16695128 0.79 ALDH1A1 (0.49) TSHRKDM2BHRH3LMNAHTR2A
SCHEMBL21036096 0.79 ALDH1A1 (0.49) TSHRKDM2BHRH3LMNAHTR2A
SCHEMBL29086901 0.78 HRH3 (0.45) HRH3
SCHEMBL1978680 0.78 ALDH1A1 (0.44) TSHRLMNAHTR2AHRH1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111479813-B Triazolobenzazepines as vasopressin V1A receptor antagonists 吉瑞工厂 2023-03-21 CN disclosed
CN-111479813-A Triazolobenzazepines as vasopressin V1A receptor antagonists 吉瑞工厂 2020-07-31 CN disclosed